Neoadjuvant preoperative chemoradiation in patients with pancreatic cancer (Q44374114)

2 December 2017

title

Neoadjuvant preoperative chemoradiation in patients with pancreatic cancer (English)

1 reference

2 December 2017

0 references

4

Bernard Lelong

1 reference

2 December 2017

Valerie Magnin

1

1 reference

2 December 2017

Vincent Moutardier

2

1 reference

2 December 2017

Marie Helene Giovannini

3

1 reference

2 December 2017

Marc Giovannini

5

1 reference

2 December 2017

Frederic Viret

6

1 reference

2 December 2017

Genevieve Monges

7

1 reference

2 December 2017

Valerie Jeanne Bardou

8

1 reference

2 December 2017

Claude Alzieu

9

1 reference

2 December 2017

Jean Robert Delpero

10

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

International Journal of Radiation Oncology Biology Physics

2 December 2017

published in

1 reference

2 December 2017

volume

55

1 reference

2 December 2017

issue

5

1 reference

2 December 2017

page(s)

1300-1304

1 reference

Adjuvant therapy for pancreatic cancer.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

Pancreatic tumors show high levels of hypoxia

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

Localized adenocarcinoma of the pancreas: the rationale for preoperative chemoradiation

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas.

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

Do preoperative biliary stents increase postpancreaticoduodenectomy complications?

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stents

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04157-3

7 January 2021

10.1016/S0360-3016(02)04157-3

Identifiers

DOI

1 reference

2 December 2017

1 reference